Neuro-Oncology: The Podcast
Neuro-Oncology: The Podcast is a show from the journal Neuro-Oncology that covers recent advances in the field. Each episode features conversations with authors of selected papers published in Neuro-Oncology and its sister journals, Neuro-Oncology Practice and Neuro-Oncology Advances. The podcast is aimed at clinicians, researchers, and others who want to stay current with neuro-oncology research and practice. It highlights key findings and gives authors a chance to explain their work in more detail.
Episodes
Hot Topics: Harnessing Dendritic Cell Recruitment and the Organization of GBM
Podcast Host and Interviewee: Host: Dr. Daniel Zamler Interviewee: Dr. Pedro Lowenstein Podcast Description: Dr. Daniel Zamler interviews Dr. Pedro Lowenstein on how recruiting dendritic cells to the tumor microenvironment has a beneficial effect, as shown in their recent clinical trial. Oncostreams and the effect of tumor organization on pathogenesis are also discussed.
SNObound: Career Advice with SaRena Eves - Certified Medical Dosimetrist
Jayden Ha interviews SaRena Eves, a certified medical dosimetrist. The episode focuses on dosimetry as a career, its education requirements, and day-to-day routine. Host: Jayden Interviewee: SaRena Eves
Hot Topics: Perspectives from EANO's Youngsters Committee
Dr. Franziska Ippen interviews Drs. George Petrescu, Marjolein Geurta, and Tobias Weiss on updates and perspectives from EANO's Youngsters Committee Podcast Host and Interviewee: Host: Franziska Ippen Interviewee: George Petrescu, Marjolein Geurts, Tobias Weiss
Hot Topics: Harnessing Dendritic Cell Recruitment and the Organization of GBM
Dr. Daniel Zamler interviews Dr. Pedro Lowenstein on how recruiting dendritic cells to the tumor microenvironment has beneficial effect as shown in their recent clinical trial. Also discussed is oncostreams and how tumor organization might be therapeutically targetable. Podcast Host and Interviewee: Host: Dr. Daniel Zamler Interviewee: Dr. Pedro Lowenstein
Hot Topics: Results from the FET-PET in Glioblastoma (FIG) Study TROG 18.06
Dr. Jan-Michael Werner interviews Dr. Siew Koh on the results of the FET-PET in Glioblastoma (FIG) Study TROG 18.06, released at EANO 2026 Podcast Host and Interviewee: Host: Jan-Michael Werner Interviewee: Siew Koh Mentioned in Episode: https://academic.oup.com/neuro-oncology/advance-article/doi/10.1093/neuonc/noag229/8832332
Hot Topics: EANO's Best Oral Presentation Award Recipient - Michael Jenkinson
Dr. Maximillian Mair interviews Dr. Michael Jenkinson, the recipient of EANO's Best Oral Presentation Award in Clinical Research for his work on the landmark ROAM trial investigating radiation versus observation following surgical resection of atypical meningioma, published in Lancet in September 2026. Podcast Host and Interviewee: Host: Maximillian Mair Interviewee: Michael Jenkinson L
Neuro-Onc Narratives: Dealing with Dr. Google
Podcast Host and Interviewee: Christopher Park, MD – Pediatric Neuro-Oncologist at VCU Sher Reed – patient mom Kassi Thomas – patient mom
Author Interview: The European Association for Neuro-oncology (EANO) Consensus Statement on Radiation Necrosis
o Host: Franziska Ippen o Interviewee(s): Johnny Duerinck and Evangelia Razis Description: In this episode of Author Interviews from the Society for Neuro-Oncology journals, Dr. Franziska Ippen interviews Drs. Johnny Duerinck and Evangelia Razis on their recent Neuro-Oncology article entitled "The European Association for Neuro-oncology (EANO) Consensus Statement on Radiation Nec
Hot Topics: Education Day Preview of EANO 2026
Dr. Iris Verploegh interviews Dr. Mihaela Lorger and Dr. Matthijs van der Meulen on what we can expect from the Education Day sessions at EANO 2026. Host: Iris Verploegh Interviewee: Mihaela Lorger, Matthijs van der Meulen
Hot Topics: Scientific Preview of EANO 2026
Host: Jan-Michael Werner Interviewee: Giuseppe Minniti, Anna Berghoff Podcast Description: Dr. Jan-Michael Werner interviews Dr. Giuseppe Minniti and Dr. Anna Berghoff on what we can expect from the scientific sessions at EANO 2026
Hot Topics: Updates from SNO's Community Neuro-oncology Committee
Host: Evan Noch Interviewees: Dr. Sajeel Chowdhary, Dr. Christine Lu-Emerson, Dr. Erin Dunbar Podcast Description: Dr. Evan Noch interviews Drs. Sajeel Chowdhary, Christine Lu-Emerson, and Erin Dunbar on their work within SNO's Community Neuro-oncology Community, latest updates, and their selection as the winners of SNO's 2026 Community Service Award.
Author Interview: BRAF altered glioma in adults and children: A society for Neuro Oncology (SNO) and European Society for Neuro Oncology (EANO) consensus review on clinical management and future directions
Host: John Fortunato Interviewee: Karisa Schreck, Marjolein Guerts Podcast Description: Dr. John Fortunato interviews Dr. Karisa Schreck and Dr. Marjolein Guerts on their recent manuscript, titled "BRAF altered glioma in adults and children: A society for Neuro Oncology (SNO) and European Society for Neuro Oncology (EANO) consensus review on clinical management and future directions."
Hot Topics: Role of Lipids in Glioma Interactions
Podcast Host and Interviewee: Host: Dr. Daniel Zamler Interviewee: Dr. Jian Hu Podcast Description: Dr. Daniel Zamler interviews Dr. Jian Hu on the multifaceted role that lipids play in the glioma microenvironment, with discussion on lipids in tumor cells, myeloid cells, and neurons.
Neuro-oncology Narratives: What happens when the provider leaves the room?
Podcast Host and Interviewee: Kate McDaniel, Becky Simpson, Podcast Description: Kate McDaniel interviews caregiver Becky Simpson on what happens when the provider leaves the room and reality sets in.
Hot Topics: Part 2: Radiation for Parenchymal Brain Metastases
Podcast Host and Interviewee: Host – Elham (El) Rahimy, MD Interviewee: Jonathan Yang, MD PhD Podcast Description: These two sessions explore leptomeningeal and parenchymal metastases from the view point of radiation oncology. We delve into the clinical approach and integration of recent trials in the decision of radiation regimens/modalities.
Hot Topics: Part 1: Radiation for Leptomeningeal Disease
Podcast Host and Interviewee: Host – Elham (El) Rahimy, MD Interviewee: Jonathan Yang, MD PhD Podcast Description: These two sessions explore leptomeningeal and parenchymal metastases from the view point of radiation oncology. We delve into the clinical approach and integration of recent trials in the decision of radiation regimens/modalities.
Author Interview: Nuclear export as a therapeutic vulnerability in ZFTA-RELA ependymoma
In this episode of Author Interviews from the Society for Neuro-Oncology journals, Dr. Jiasen He (UT MD Anderson Cancer Center) speaks with Dr Stephen C. Mack and Dr. Kelsey C. Bertrand from St. Jude Children's Research Hospital about their recently published article in Neuro-Oncology titled 'Nuclear export as a therapeutic vulnerability in ZFTA-RELA ependymoma Authors: Stephen C. Mack, Kelsey C.
Hot Topics: Leptomeningeal Disease and Liquid Biopsy
Podcast Host: Ramya Tadipatri Podcast Interviewee: Na Tosha Gatson Podcast Description: Dr. Ramya Tadipatri interviews Dr. Na Tosha Gatson on the evolving landscape of leptomeningeal disease with a focus on liquid biopsy.
Neuro-Oncology Nugget: Synthetic Super-Enhancer Gene Therapy for Glioblastoma
Podcast Host and Interviewee: Shahad Abdulsahib, PhD Graduate, UT Health San Antonio Podcast Description: Shahad Abdulsahib discusses a landmark preclinical study evaluating Synthetic Super-Enhancer-based gene therapy for glioblastoma, published in Nature in April 2026, and the rapid translation of these findings into the first-in-human Phase 1/2 ADePT clinical trial with first patient dosing in M
Hot Topics: Integrative Neuro-Oncology
Podcast Host and Interviewee: Host (Ashley Aaroe, MD) | Guests (Akanksha Sharma, MD, Soma Sengupta, MD, PhD, MBA) Podcast Description: This episode discusses what it means to practice integrative medicine in a neuro-oncology clinic, joined by guests Akanksha Sharma, MD (Sutter Health) and Soma Sengupta, MD, PhD, MBA (Tufts) - two neuro-oncologists whose work sits at the intersection of tumor-di
SNOBound: Career Advice with Dr. Justin Lathia
Podcast Host and Interviewee: Host: Jayden Ha Interviewee: Dr. Justin Lathia In This Episode Jayden Ha interviews Dr. Justin Lathia, focusing on neuro-oncology research development, future innovations and general career advice.
Author Interviews: cIMPACT-NOW update 12: Refining Pathology-based Risk Stratification and Grading for IDH-mutant Gliomas
· Podcast Host and Interviewee: o Host: Franziska Ippen o Interviewee: Daniel Brat Podcast Description: Dr. Franziska Ippen interviews Dr. Daniel Brat on his recent Neuro-oncology article entitled "cIMPACT-NOW update 12: Refining Pathology-based Risk Stratification and Grading for IDH-mutant Gliomas".
A Conversation on Career Journeys with SNO's Young Investigator Committee Chairs
Host: Evan Noch; Interviewees: Jasia Mahdi, Jacob Young, Alireza Mansouri Evan Noch interviews the Co-chairs of SNO's Young Investigator Committee about their advice on career journeys for early-career trainees
Neuro-onc Narratives: Two Insiders, One Diagnosis: A Neurosurgeon and Healthcare Leader on Living with GBM
Host: Akanksha Sharma, MD Interviewee: Shannon Thomas, RN, MSN Podcast Description: Dr Sharma has a candid, reflective conversation with Shannon Thomas, CEO of Eden Medical Center in Castro Valley, CA, and the wife of Dr. Ronnie Mimran – a beloved physician and highly skilled neurosurgeon known for his patient care and bedside manner. Dr Mimran is living with glioblastoma; he was diagnosed almos
Ivosidenib in predominantly recurrent IDH1-mutant glioma: A single-institution experience
Podcast Host and Interviewee: Host: John Fortunato Interviewee: Sofia Rael, Ugur Sener Podcast Description: Dr. John Fortunato interviews Dr. Sofia Rael and Dr. Ugur Sener on their recent manuscript, titled "Ivosidenib in predominantly recurrent IDH1-mutant glioma: A single institution experience."
Author Interview: Prospective biopsy-controlled validation of an AI model for predicting glioblastoma infiltration: Results from the SupraGlio trial
· Podcast Host and Interviewee: Host: Maya GrahamInterviewee: Santiago Cepeda Description Dr. Maya Graham interviews Dr. Santiago Cepeda on his recent Neuro-oncology article entitled "Prospective biopsy-controlled validation of an AI model for predicting glioblastoma infiltration: Results from the SupraGlio trial."
Neuro-Oncology Nugget: GT-20 Phase 1 Trial — Personalized Neoantigen DNA Vaccine for MGMT Unmethylated Glioblastoma
Host/Interviewee: ç, PhD Candidate, UT Health San Antonio Description: Shahad Abdulsahib discusses the GT-20 phase 1 clinical trial evaluating GNOS-PV01, a personalized multivalent neoantigen DNA vaccine administered following surgical resection and radiation in patients with MGMT unmethylated glioblastoma, with findings published in Nature Cancer on May 12th, 2026.
Author Interview Series SNO Podcast May 2026
Podcast Host and Interviewee: Dr. Haseeb Mehmood Qadri interviews Prof. Dr. Ghazaleh Tabatabai Dr. Haseeb Mehmood Qadri interviews Prof. Dr. Ghazaleh Tabatabai from the Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Germany on their manuscript, entitled Clinical outcome of biomarker-guided thera
Neuro-Oncology Narrative
Podcast Host and Interviewee: Rachna Malani, Sarah Menacho, Ben Shofty Rachna Malani interviews Drs. Menacho and Shofty, two Neurosurgeons who share their experiences in interfacing with Neurosurgery as well as their experiences as Neurosurgeons.
Hot Topics: Wellness in Neuro-oncology
Podcast Host and Interviewee: Venina Kalistratova (host), Nick Gonzalez Castro and Raj Mukherjee (Interviewees) Podcast Description: The Co-chairs of the SNO Wellness Committee discuss wellness and ways to reduce burnout.
Neuro-Oncology Nugget: Phase 1/2 BT008NA Trial — Focused Ultrasound + Temozolomide for High-Grade Glioma
Host/Interviewee: Shahad Abdulsahib, PhD Graduate, UT Health San Antonio Description: Shahad Abdulsahib discusses the phase 1/2 BT008NA clinical trial evaluating microbubble-enhanced transcranial focused ultrasound combined with temozolomide in patients with newly diagnosed high-grade glioma, with findings published in The Lancet Oncology in December 2025
SNObound: Career description and advice from Dr. Ryan Cecchi in Neuropathology
Podcast Host and Interviewee: Dr. Shreya Louis (host), Dr. Ryan Cecchi (interviewee) Podcast Description: Dr. Shreya Louis interview Dr. Ryan Cecchi on his career in academic neuropathology focusing on the path to neuro-pathology, interesting developments in the field, and advise for trainees interested in neuro-oncology and neuropathology
CATNON Conclusion: Closure on concurrent chemotherapy in IDHmt Grade 3 Astrocytoma
Podcast Host and Interviewee: Host: Franziska Ippen Interviewee: David Schiff Podcast Description: Dr. Franziska Ippen interviews Dr. David Schiff on his recent manuscript entitled "CATNON Conclusion: Closure on concurrent chemotherapy in IDHmt Grade 3 Astrocytoma"
Hot Topics: What's next in neuro-oncology
Podcast Host and Interviewee: Host: Dr. Dave Rogawski Interviewee: Dr. Fabio Iwamoto Dr. Dave Rogawski interviews Dr. Fabio Iwamoto, incoming Neuro-Oncology Division Chief at Stanford, about where we're headed in neuro-oncology.
Neuro-Oncology Nugget: Career Development Outreach from SNO
Podcast Host and Interviewee: Evan Noch, Producer, Neuro-oncology: The Podcast Podcast Description: Evan Noch discusses recent career development outreach from SNO
Neuro-onc Narratives: An Interview with Caroline Catlin
Podcast Host and Interviewee: Host: Sara Hardy; Interviewee: Caroline Catlin Caroline Catlin is an artist and also a brain tumor survivor. Her writing and photography can be found in The New York Times, Longreads, Huffington Post, Glamour, and elsewhere. She has an MFA in Writing from Pacific University and a forthcoming memoir in progress, represented by Neon Literary. Her TED talk, Why
Author Interview: "DNA copy number patterns reveal prognostic markers and elucidate mechanisms of evolution in IDH-mutant astrocytoma"
Podcast Host and Interviewee: Host: John Fortunato Interviewee: Bob Jenkins Podcast Description: Dr. John Fortunato interviews Dr. Bob Jenkins on his recent manuscript, titled "DNA copy number patterns reveal prognostic markers and elucidate mechanisms of evolution in IDH-mutant astrocytoma."
Hot Topics: AYA in Neuro-Oncology
Dr. Dave Rogawski interviews Dr. Mary Jane (MJ) Lim-Fat and Dr. Kee Kiat (Aaron) Yeo on patient care and research for the adolescent and young adult (AYA) population in neuro-oncology.
Neuro-Oncology Nugget: Bivalent EGFR/IL13Rα2 CAR T Cells for Recurrent Glioblastoma
Shahad Abdulsahib discusses a phase 1 clinical trial of intracerebroventricular bivalent EGFR and IL13Rα2 CAR T cells for recurrent glioblastoma, published in Nature Medicine.
SNObound: Career Advice from Dr. Brooke Braman in Radiation Oncology
Jayden Hang and Dr. Michael Dohopolski interview Dr. Brooke Braman about her training path as a radiation oncology resident.
Author Interview: Global analysis of clinical trials for children and adolescents with CNS tumors
In this episode of Author Interviews, Dr. Jiasen He speaks with Dr. Margit K. Mikkelsen and Dr. Daniel C. Moreira from St. Jude Children's Research Hospital about their article, "Global Analysis of Clinical Trials for Children and Adolescents with CNS Tumors," published in Neuro-Oncology Pediatrics.
Neuro-Oncology Nugget: Intracerebroventricular B7-H3 CAR T Cells for DIPG
Shahad Abdulsahib discusses a phase 1 clinical trial of intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma, published in Nature Medicine in January 2025.
Neuro-onc Narratives: Advocating for patient well-being in neuro-oncology
Dr. Sara Hardy interviews Drs. Ashlee Loughan and Sarah Braun to talk about their groundbreaking work to improve quality of life for patients with brain tumors.
Author Interview: Visual morbidity, long-term outcome, and prognostic factors in infants and young children with optic pathway low-grade glioma
Dr. John Fortunato interviews Dr. Stefania Picariello and Dr. Enrico Opocher on their manuscript, entitled "Visual morbidity, long-term outcome, and prognostic factors in infants and young children with optic pathway low-grade glioma."
Hot Topics: Clinician-Patient Relationship in Neuro-Oncology
Dr. Dave Rogawski interviews Dr. Akanksha Sharma on how we can optimize the meaningful, longitudinal relationships that drew many of us to the field.
Neuro-Oncology Nugget: Targeted Radiotherapy Using Rhenium-186 Nanoliposomes for Recurrent Glioma
Podcast Host and Interviewee: Shahad Abdulsahib, PhD Candidate, UT Health San Antonio Podcast Description: Shahad Abdulsahib discusses a recent Phase 1 clinical trial on Rhenium-186 nanoliposome therapy for recurrent glioma, published in Nature Communications in March 2025.
SNObound: Career Advice from Dr. Gelareh Zadeh
Dr. Alex Landry interviews Dr. Gelareh Zadeh on her career in academic neurosurgical oncology, focusing on the role of mentorship, how the field has evolved over time, and advice for junior trainees entering the field.
Author Interview: Ibrutinib for newly diagnosed primary CNS lymphoma
Dr. Maya Graham interviews Dr. Lauren Schaff on her manuscript entitled "Ibrutinib in combination with rituximab, methotrexate, vincristine, and procarbazine (R-MVP/i) for newly diagnosed primary CNS lymphoma (PCNSL)," published in Neuro-Oncology in January 2026.
Hot Topics: Radiation Hypofractionation in Glioma
Dr. Nathan Dalton interviews Dr. Joseph Sia on the topic of radiation hypofractionation – its history, current clinical landscape, and potential future developments for patients with gliomas.
Neuro-Oncology Nugget: Targeting CDK8 in MYC-Driven Medulloblastoma
Shahad Abdulsahib discusses the findings of a recent paper, entitled "Transcriptional regulation of protein synthesis by mediator kinase represents a therapeutic vulnerability in MYC-driven medulloblastoma", which was published in Nature Communications in December 2025.
Neuro-Onc Narratives: Patient Services at the American Brain Tumor Association
Dr. Rachna Malani interviews Mindy Freund about her work at the American Brain Tumor Association
Author Interview: Post-irradiation chemotherapy in patients with newly diagnosed ependymoma
Dr. Jasmin Jo interviews Dr. Amy Smith and Dr. David Ellison on their manuscript, entitled "Phase 3 randomized trial of post-irradiation chemotherapy in patients with newly diagnosed ependymoma, a report from the Children's Oncology Group" published in Neuro-Oncology in December 2025.
Hot Topics: How longitudinal profiling of glioma informs therapy development
Dr. Dave Rogawski interviews Dr. David Solomon on his research that sheds light on how key genomic alterations in high-grade glioma evolve over time and how these insights might inform therapeutic development.
Neuro-oncology Nugget: Microbubble-enhanced transcranial focused ultrasound with temozolomide for patients with high-grade glioma
Dr. Haseeb Mehmood discusses the use of microbubble-enhanced transcranial focused ultrasound combined with standard temozolomide in high-grade glioma.
SNObound: Career Advice from Neuro-oncologist, Dr. Lisa DeAngelis
Dr. Evan Noch interviews Dr. Lisa DeAngelis about her career in neuro-oncology, role as Chair of Neurology and Physician-in-Chief at Memorial Sloan Kettering Cancer Center, and advice for trainees entering the field.
Author Interview: Pamiparib and TMZ in recurrent IDHmt gliomas
Dr. Iyad Alnahhas interviews Drs. David Schiff and Ranjit Bindra about their recent manuscript entitled "Phase I/II and Window-of-Opportunity Study of Pamiparib and Metronomic Temozolomide for Recurrent IDH Mutant Gliomas", published online in Neuro-Oncology in October 2025.
Introduction to Neuro-Oncology: The Podcast 2.0
In this episode, Dr. Evan Noch and Dr. Maya Graham discuss the exciting new podcast subtypes and the episodes to come.
Radiotherapy induced neurocognitive decline
Description: Dr. Iyad Alnahhas interviews Dr. Charlotte Sleurs about her and her team's recent manuscript entitled: "Radiotherapy-induced neurocognitive decline among adult intracranial tumor patients: A voxel-based approach", published online in Neuro-Oncology in May 2025.
QOL and cognitive functioning in patients with oligodendroglioma
Dr. Iyad Alnahhas interviews Drs. Florien Boele and Martin Klein about their recent manuscript entitled: "Health-related quality of life and cognitive functioning in survivors of oligodendroglioma: An international cross-sectional investigation", published online in Neuro-Oncology in July 2025.
Post-operative radiation in recurrent grade 1 meningiomas
Dr. Iyad Alnahhas interviews Drs. Felix Sahm and Maximilian Deng about their recent manuscript entitled: "Postoperative radiotherapy in subtotally-resected recurrent WHO grade 1 meningiomas with intermediate/ high-risk molecular profiles", published online in Neuro-Oncology in May 2025.
mRNA CAR T against GD2 in high-grade glioma models
Dr. Maya Graham interviews Dr. Jessica Foster about her and her team's recent manuscript, entitled "Transient mRNA CAR T cells targeting GD2 provide dose-adjusted efficacy against diffuse midline glioma and high-grade glioma models". This work was published online in Neuro-Oncology in May 2025.
A transcriptomic atlas of CNS tumors
Dr. Evan Noch interviews Dr. Akshitkumar Mistry about his and his team's recent manuscript entitled "A clinically annotated transcriptomic atlas of nervous system tumors", published online in Neuro-Oncology in May 2025 Link to the paper: https://academic.oup.com/neuro-oncology/advance-article/doi/10.1093/neuonc/noaf130/8151442
Gut microbiome in primary CNS lymphoma
Dr. Iyad Alnahhas interviews Drs. Isaias Hernandez-Verdin and Agusti Alentorn about their recent manuscript entitled: "Gut microbiome modulates the outcome in primary central nervous system lymphoma patients undergoing chemotherapy: An ancillary study from the BLOCAGE trial", published online in Neuro-Oncology in March 2025 Link: https://academic.oup.com/neuro-oncology/advance-article/doi/10.109
Germline analysis of diffuse midline glioma
Dr. Evan Noch interviews Dr. Marion Mateos about her and her team's recent manuscript entitled: "Germline analysis of an international cohort of pediatric diffuse midline glioma patients", published online in Neuro-Oncology in March 2025.
The proteomic landscape of diffuse midline glioma
Dr. Iyad Alnahhas interviews Drs. Cynthia Hawkins and Arun Vadivel about their recent manuscript entitled: "The proteomic landscape of diffuse midline glioma highlights the therapeutic potential of non-histone protein methyltransferases", published online in Neuro-Oncology in February 2025. More Information
Radio-Pathomic maps and MR perfusion
Dr. Iyad Alnahhas interviews Dr. Peter LaViolette about his and his team's recent manuscript entitled: "Multi-Site Retrospective Analysis of Diffusion and Perfusion MRI Correlates to Glioma Characteristics Derived from Radio-Pathomic Maps", published online in Neuro-Oncology in February 2025.
CSF proteomics in glioma
Description: Dr. Evan Noch interviews Drs. Cecile Riviere-Cazaux and Terry Burns about their recent manuscript entitled: "A field resource for the glioma cerebrospinal fluid proteome: impacts of resection and location on biomarker discovery", published online in Neuro-Oncology in December 2024. Link: https://doi.org/10.1093/neuonc/noae277
Vorasidenib in IDH mutant glioma
Description: Dr. Ankush Bhatia interviews Drs. Macarena de la Fuente and Mehdi Touat about their recent manuscript entitled: "The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma" published online in Neuro-Oncology in December 2024. Link: https://doi.org/10.1093/neuonc/noae259
KL-50 in post TMZ MMR-deficient GBM
Dr. Iyad Alnahhas interviews Dr. Craig Horbinski about his and his team's recent manuscript entitled "The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma", published online in Neuro-Oncology in December 2024.
Measurable disease per FET-PET vs MRI in GBM
Dr. Iyad Alnahhas interviews Dr. Nathalie Albert about her and her team's recent manuscript entitled: "Measurable disease as baseline criterion for response in glioblastoma: A comparison of PET-based (PET RANO 1.0) and MRI-based (RANO) assessments", published online in Neuro-Oncology in January 2025.
Pre-radiation chemotherapy in GBM
Dr. Iyad Alnahhas interviews Dr. Danielle Bazer about her and her team's recently published manuscript, entitled: Using a Pre-Radiation Window to Identify Potentially Active Cytotoxic Agents in Adults with Newly Diagnosed Glioblastoma", published online in Neuro-Oncology in November 2024.
cIMPACT-NOW Update 8: grading of meningiomas
Dr. Rachna Malani interviews Drs. Felix Sahm and Arie Perry about their recent manuscript entitled: "cIMPACT-NOW Update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas", published online in Neuro-Oncology in August 2024 Read More
Residual tumor volume and survival after CCNU/TMZ in GBM
Dr. Iyad Alnahhas interviews Drs. Thomas Zeyen and Johannes Weller about their recent manuscript entitled: "Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with CCNU/TMZ", published online in Neuro-Oncology in October 2024.
Alterations in RNA splicing between meningioma DNA methylation groups
Dr. Evan Noch interviews Drs. Nathan Leclair, David Raleigh and Olga Anczukow about their recent manuscript entitled: "RNA splicing as a biomarker and phenotypic driver of meningioma DNA methylation groups", published online in Neuro-Oncology in August 2024.
The immune landscape of IDH mutant and IDHwt glioma
Dr. Evan Noch interviews Drs. Pravesh Gupta and Krishna Bhat about their recent manuscript entitled "Immune landscape of isocitrate dehydrogenase-stratified primary and recurrent human gliomas", published online in Neuro-Oncology in August 2024 Read Paper
Equity-driven applications of AI in neuro-oncology
Dr. Iyad Alnahhas interviews Dr. Mulki Mehari about her and her team's recent manuscript entitled: "Enhancing neuro-oncology care through equity-driven applications of artificial intelligence", published online in Neuro-Oncology in August 2024.
IDH mutant glioma across age groups
Dr. Maya Graham interviews Drs. Mary Jane Lim-Fat and Kee Kiat Yeo about their recent manuscript entitled "A comparative analysis of IDH-mutant glioma in pediatric, young adult, and older adult patients", published online in Neuro-Oncology in July 2024. Link: https://doi.org/10.1093/neuonc/noae142
Contemporary molecular prognostic signatures in glioma
Dr. Iyad Alnahhas interviews Dr. Linda Bi, Hia Ghosh and Ruchit Patel about their recent manuscript entitled: "Contemporary Prognostic Signatures and Refined Risk Stratification of Gliomas: An Analysis of 4400 Tumors", published online in Neuro-Oncology in August 2024. More Information: https://academic.oup.com/neuro-oncology/advance-article/doi/10.1093/neuonc/noae164/7737688
FDG PET in PCNSL
Dr. Iyad Alnahhas interviews Drs. Minyoung Oh and Hyungwoo Cho about their recent manuscript entitled: "Enhancing Prognostication and Treatment Response Evaluation in Primary CNS Lymphoma with 18F-FDG PET/CT", published online in Neuro-Oncology in August 2024. Link to manuscript
TMZ and MGMT in elderly GBM patients
Dr. Jasmin Jo interviews Dr. Monika Hegi about her and her team's recent manuscript entitled: "No benefit from TMZ treatment in GB with truly unmethylated MGMT promoter: Reanalysis of the CE.6 and the pooled Nordic/NOA-08 trials in elderly GB patients", published online in Neuro-Oncology in (I will fill in through Libsyn)
